Search results for MEF2A Antibody

Anti-MEF2A antibody [EPR1451], Abcam, AB109420

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

PE Anti-MEF2A antibody [EP1706Y], Abcam, AB318324

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

MEF2A antibody [N1N2], N-term, Genetex, GTX101163

MEF2A antibody [C2C3], C-term, Genetex, GTX101286

APC Anti-MEF2A antibody [EP1706Y], Abcam, AB318427

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

MEF2A Antibody (YA3209)(PBS only), MedChemexpress, HY-P83464A

MEF2A Antibody (YA3209) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to MEF2A.

Anti-MEF2A antibody - C-terminal, Abcam, AB227120

Myocyte Enhancer Factor 2A (MEF2A) Antibody, Abbexa, abx113920

Myocyte Enhancer Factor 2A Antibody is a Rabbit Polyclonal antibody against Myocyte Enhancer Factor 2A.

Myocyte Enhancer Factor 2A (MEF2A) Antibody, Abbexa, abx126141

MEF2A Antibody is a Rabbit Polyclonal against MEF2A.

Myocyte Enhancer Factor 2A (MEF2A) Antibody, Abbexa, abx007355

MEF2A Antibody is a Rabbit Polyclonal Antibody against MEF2A.